PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration for Targeted Alpha Therapy Candidate Olema Pharmaceuticals OLMA Q1 2026 Earnings Narrower Loss Surprises Shares Edge Higher Gold Faces Potential Headwinds Amid Trumps Renewed Iran Deal Push